Novel Dual GIP/GLP-1 Receptor Agonists: The Future Standard of Diabetes Care? [JwqwFsTuh]
Novel Dual GIP/GLP-1 Receptor Agonists: The Future Standard of Diabetes Care? [JwqwFsTuh]
Join 3 experts in discussion about the potential role of dual incretin agonist peptides in patients with type 2 diabetes. Credit available for this activity expires: 12/20/2022 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/964951?src=mkm_podcast_addon_964951
Related Videos :
- World's Craziest Beater Car - Extreme Weight Reduction Honda [f8fbn753s]
- Hibiscus Iced Tea 🌺 My Favorite Herbal Tea For Weight Loss!!! #shorts #hibiscus #weightloss [MTwtbXaRx]
- KELLY CLARKSON WILL NOT REVEAL!! [DcUfVIR1N]
- Kim Kardashian loses weight for dress at Met Gala 2022 [gJzsvkXiq]
- Facelift after Massive Weight Loss [Ps5BItZ8W]
Aired: December 3rd 2024
Buy Now:
Novel Dual GIP/GLP-1 Receptor Agonists: The Future Standard of Diabetes Care? [JwqwFsTuh]
Fixed iFrame
Responsive iFrame
Problems Playing Video? | Closed Captioning
